These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 4942184)

  • 21. Carbon monoxide releasing molecule-2 increases the velocity of thrombus growth and strength in hemophilia A, hemophilia B and factor VII-deficient plasmas.
    Nielsen VG; Kirklin JK; George JF
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):41-5. PubMed ID: 19923981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Molecular-biology findings on various blood clotting factors].
    Fiedler H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(2):121-39. PubMed ID: 4122840
    [No Abstract]   [Full Text] [Related]  

  • 23. Haemostasis in kala-azar.
    Basu AK; Chatterjea JB; Sen Gupta PC; Mukherjee AM
    Trans R Soc Trop Med Hyg; 1970; 64(4):581-7. PubMed ID: 5485617
    [No Abstract]   [Full Text] [Related]  

  • 24. [Thromboplastic activity of brain extracts from various species in normal plasma and in congenital factor VII deficient plasma from dogs].
    von Schaewen H
    Berl Munch Tierarztl Wochenschr; 1972; 85(8):149-52. PubMed ID: 5027610
    [No Abstract]   [Full Text] [Related]  

  • 25. Tissue factor-like activity of the human monocytic tumor cell line U937.
    Hudig D; Bajaj SP
    Thromb Res; 1982 Aug; 27(3):321-32. PubMed ID: 6753233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coagulation changes induced by endotoxin and purified contact activation product.
    Barth P; Zimmermann R
    Thromb Diath Haemorrh; 1972 Oct; 28(2):280-8. PubMed ID: 4639660
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of the C1q complement subcomponent on blood coagulability and fibrinolysis].
    Lozhkina AN; Aleshkin VA
    Biull Eksp Biol Med; 1986 Mar; 101(3):265-6. PubMed ID: 3485453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preliminary characterization of the procoagulant material in human ascites.
    Addonizio VP; Fisher CA; Strauss JF; Ewan VA; Rickles FR; Rosato EF; Harken AH; Inouye WY
    Surgery; 1987 Jun; 101(6):753-62. PubMed ID: 3589968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laboratory diagnosis of congenital coagulation defects.
    Lowe GD; Forbes CD
    Clin Haematol; 1979 Feb; 8(1):79-94. PubMed ID: 310747
    [No Abstract]   [Full Text] [Related]  

  • 30. THE ACTIVATION OF FACTOR X BY EXTRACTS OF RABBIT BRAIN.
    NEMERSON Y; SPAET TH
    Blood; 1964 May; 23():657-68. PubMed ID: 14142504
    [No Abstract]   [Full Text] [Related]  

  • 31. [Blood platelets of hemophilia patients].
    Weibbbach G; Bührdel P; Domula M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 100(1):131-43. PubMed ID: 4128511
    [No Abstract]   [Full Text] [Related]  

  • 32. Standardization of laboratory tests for controlling anticoagulent therapy.
    Zucker S; Cathey MH; Sox PJ; Hall EC
    Am J Clin Pathol; 1970 Mar; 53(3):348-54. PubMed ID: 5416772
    [No Abstract]   [Full Text] [Related]  

  • 33. [Factors V, VII, and X--interpretation of test results].
    Fukutake K; Ukita M
    Nihon Rinsho; 1973; 31():1734-9. PubMed ID: 4582277
    [No Abstract]   [Full Text] [Related]  

  • 34. [Significance of thromboplast in the occurrence of the disseminated intravascular coagulation syndrome].
    Kase F
    Probl Gematol Pereliv Krovi; 1981 Jul; 26(7):41-4. PubMed ID: 7279897
    [No Abstract]   [Full Text] [Related]  

  • 35. Prolonged prothrombin time and partial thromboplastin time in disseminated intravascular coagulation not due to deficiency of factors V and VIII.
    Mant MJ; Hirsh J; Pineo GF; Luke KH
    Br J Haematol; 1973 Jun; 24(6):725-34. PubMed ID: 4716056
    [No Abstract]   [Full Text] [Related]  

  • 36. [Blood coagulation and serum lipids in pregnant rats following endotoxin injection--studies of the Sanarelli-Shwartzmann phenomenon].
    Obst R; Jannakopulos E; Urbaschek B; Huth K; Müller-Berghaus G
    Thromb Diath Haemorrh; 1971 Dec; 26(3):474-87. PubMed ID: 4947420
    [No Abstract]   [Full Text] [Related]  

  • 37. STUDIES ON BLOOD COAGULATION FACTORS IN A CASE OF LIVER CIRRHOSIS. REMISSION OF THE HEMORRHAGIC TENDENCY ON TREATMENT WITH HEPARIN.
    JOHANSSON SA
    Acta Med Scand; 1964 Feb; 175():177-83. PubMed ID: 14124632
    [No Abstract]   [Full Text] [Related]  

  • 38. [DIAGNOSTIC PROBLEMS IN CASES OF HEMORRHAGE].
    HORANYI M
    Orv Hetil; 1964 Jun; 105():1119-23. PubMed ID: 14163246
    [No Abstract]   [Full Text] [Related]  

  • 39. The kaolin partial thromboplastin time as a screening test for coagulation disorders.
    Lurie A; Smith S
    S Afr Med J; 1968 May; 42(18):438-44. PubMed ID: 5655371
    [No Abstract]   [Full Text] [Related]  

  • 40. The partial thromboplastin time test: distinction between inhibitor and clotting-factor deficiency.
    Knights SF; Wadey CA
    Med Lab Technol; 1973 Jan; 30(1):43-7. PubMed ID: 4718028
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.